Following in the footsteps of the other review programs at the US Food and Drug Administration's (FDA) Office of Pharmaceutical Science, the Office of Biotechnology Products (OBP) is currently in ...

This article summarizes the authors’ JV’s recent development of two new improved catalytic materials for the residue desulfurization (RDS) process, and provides a case study showing how these ...